| Current Price | $1.00 | Mkt Cap | $10.52M |
|---|---|---|---|
| Open | $1.03 | P/E Ratio | 0.00 |
| Prev. Close | $1.04 | Div. (Yield) | N/A (N/A) |
| Daily Range | $1.00 - $1.06 | Volume | 202,996 |
| 52-Wk Range | $0.95 - $3.20 | Avg. Daily Vol. | 0 |
News & Discussion Boards
- ARCA biopharma Announces Additional Patent Issued for Methods for Treatment with Bucindolol Based on Genotype of Patient 1/19/2012 8:00:00 AM -
- Biggest Nasdaq Changes in Short Interest vs Float as of Dec. 30 1/11/2012 8:00:17 PM -
- Largest Nasdaq Short Interest Percent Increases as of Dec. 30 1/11/2012 8:00:12 PM -
- CEO of ARCA biopharma to Speak on Use of Biomarkers and Implications of Personalized Medicine at New Paradigms Conference on January 12, 2012 1/5/2012 8:00:00 AM -
Sorry no Fool articles available for ABIO.
| Subject | Recs | Author | Date |
|---|



